Подписаться
Anatoliy Burlaka,  Anatoley Burlaka
Anatoliy Burlaka, Anatoley Burlaka
oncologist, Doctor Sciences RE Kavetsky Institute of Experimental Pathology, Oncology
Подтвержден адрес электронной почты в домене onconet.kiev.ua - Главная страница
Название
Процитировано
Процитировано
Год
Overproduction of free radical species in embryonal cells exposed to low intensity radiofrequency radiation
A Burlaka, O Tsybulin, E Sidorik, S Lukin, V Polishuk, S Tsehmistrenko, ...
Experimental oncology, 219-225, 2013
1112013
Magnetic properties and antitumor effect of nanocomplexes of iron oxide and doxorubicin
V Orel, A Shevchenko, A Romanov, M Tselepi, T Mitrelias, CHW Barnes, ...
Nanomedicine: Nanotechnology, Biology and Medicine 11 (1), 47-55, 2015
1052015
Iron metabolism disturbances in the MCF-7 human breast cancer cells with acquired resistance to doxorubicin and cisplatin
VF Chekhun, NY Lukyanova, АP Burlaka, NA Bezdenezhnykh, ...
International journal of oncology 43 (5), 1481-1486, 2013
992013
Using water-soluble C60 fullerenes in anticancer therapy
SV Prylutska, AP Burlaka, PP Klymenko, II Grynyuk, YI Prylutskyy, ...
Cancer nanotechnology 2, 105-110, 2011
942011
Pristine C60 fullerenes inhibit the rate of tumor growth and metastasis
SV Prylutska, AP Burlaka, YI Prylutskyy, U Ritter, P Scharff
Experimental Oncology, 2011
912011
C60 fullerene enhances cisplatin anticancer activity and overcomes tumor cell drug resistance
S Prylutska, R Panchuk, G Gołuński, L Skivka, Y Prylutskyy, V Hurmach, ...
Nano Research 10, 652-671, 2017
822017
Hyperthermic effect of multi-walled carbon nanotubes stimulated with near infrared irradiation for anticancer therapy: in vitro studies
A Burlaka, S Lukin, S Prylutska, O Remeniak, Y Prylutskyy, M Shuba, ...
Experimental oncology, 2010
772010
Catalytic system of the reactive oxygen species on the C60 fullerene basis.
AP Burlaka, YP Sidorik, SV Prylutska, OP Matyshevska, OA Golub, ...
Experimental oncology 26 (4), 326-327, 2004
732004
Proteomic profiling of cancer stem cells derived from primary tumors of HER2/Neu transgenic mice
D Kanojia, W Zhou, J Zhang, C Jie, PK Lo, Q Wang, H Chen
Proteomics 12 (22), 3407-3415, 2012
542012
Therapeutic reactive oxygen generation
P Scharff, U Ritter, OP Matyshevska, SV Prylutska, II Grynyuk, AA Golub, ...
Tumori Journal 94 (2), 278-283, 2008
522008
Stomach cancer: interconnection between the redox state, activity of MMP-2, MMP-9 and stage of tumor growth
AP Burlaka, II Ganusevich, MR Gafurov, SM Lukin, EP Sidorik
Cancer Microenvironment 9, 27-32, 2016
492016
Effects of radical oxygen species and NO: formation of intracellular hypoxia and activation of matrix metalloproteinases in tumor tissues
AP Burlaka, EP Sidorik, ІІ Ganusevich, SP Osinsky
Experimental Oncology, 2006
482006
Радикальні форми кисню та оксиду азоту при пухлинному процесі
АП Бурлака
Наукова Думка, 2006
442006
Heterogeneity in tumor chromatin-doxorubicin binding revealed by in vivo fluorescence lifetime imaging confocal endomicroscopy
H Sparks, H Kondo, S Hooper, I Munro, G Kennedy, C Dunsby, P French, ...
Nature communications 9 (1), 2662, 2018
402018
Changes in mitochondrial functioning with electromagnetic radiation of ultra high frequency as revealed by electron paramagnetic resonance methods
ES Anatoly Burlaka, Marina Selyuk, Marat Gafurov, Sergei Lukin, Viktoria ...
International Journal of Radiation Biology 90 (5), 357-362, 2014
402014
Changes in mitochondrial functioning with electromagnetic radiation of ultra high frequency as revealed by electron paramagnetic resonance methods
A Burlaka, M Selyuk, M Gafurov, S Lukin, V Potaskalova, E Sidorik
International Journal of Radiation Biology 90 (5), 357-362, 2014
402014
Significance of ferritin expression in formation of malignant phenotype of human breast cancer cells
SV Chekhun, NY Lukyanova, YV Shvets, AP Burlaka, LG Buchynska
Experimental oncology, 179-183, 2014
382014
Oxidative and mutagenic effects of low intensity GSM 1800 MHz microwave radiation
I Yakymenko, A Burlaka, A Tsybulin, O Brieieva, L Buchynska, ...
252018
Mechanochemically activated doxorubicin nanoparticles in combination with 40 MHz frequency irradiation on A-549 lung carcinoma cells
VE Orel, YI Kudryavets, S Satz, NA Bezdenezhnih, ML Danko, ...
Drug Delivery 12 (3), 171-178, 2005
232005
Nanomagnetic modulation of tumor redox state
VE Orel, M Tselepi, T Mitrelias, A Rykhalskyi, A Romanov, VB Orel, ...
Nanomedicine: Nanotechnology, Biology and Medicine 14 (4), 1249-1256, 2018
192018
В данный момент система не может выполнить эту операцию. Повторите попытку позднее.
Статьи 1–20